Ampersand

is a Massachusetts-based biotechnology platform that researches and develops programmable drugs to precisely treat the affected body part...
Read more
Ampersand CEO: Jason Gardner

CEO

Jason Gardner

CEO Approval Rating

90/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$115M
Acquisitions
1

Ampersand Competitors

1Asimov
2Laronde
3Strand
4Alnylam
5Amunix
6Arrowhead
7Ra Pharma
8Voyager
9Regulus
10Genentech

Trending Companies